Pfizer Inc.
27.78USD
-0.0100 (-0.04%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.76▼ | $0.85 | 1 | 14 |
| Next quarter | $0.71▲ | $0.69 | 11 | 4 |
| Current year | $2.98▲ | $2.96 | 15 | 4 |
| Next year | $2.9▲ | $2.84 | 15 | 4 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.68 | $0.77 | +0.09 (+12.9%) |
| 2026-03-31 | $0.72 | $0.75 | +0.03 (+3.9%) |
| 2025-12-31 | $0.57 | $0.66 | +0.09 (+16.2%) |
| 2025-09-30 | $0.63 | $0.87 | +0.24 (+37.4%) |
301 ratings from 39 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Guggenheim | Maintained | Buy | $35 $31 | Aug 7, 2026 |
| BMO Capital | Maintained | Outperform | $34 $30 | Jul 13, 2026 |
| Guggenheim | Maintained | Buy | $36 $35 | Jul 13, 2026 |
| B of A Securities | Maintained | Neutral | $27 $26 | Jul 10, 2026 |
| JP Morgan | Maintained | Neutral | $30 $28 | Jul 8, 2026 |
| Cantor Fitzgerald | Reiterated | Neutral | $27 | Jul 6, 2026 |
| HSBC | Downgraded from Buy | Hold | $32 $28 | Jul 6, 2026 |
| RBC Capital | Upgraded from Underperform | Sector Perform | $25 | Jun 10, 2026 |
| Citigroup | Maintained | Neutral | $26 $27 | Apr 29, 2026 |
| RBC Capital | Reiterated | Underperform | $25 | Apr 20, 2026 |
| CICC | Initiated | Outperform | $33 | Apr 16, 2026 |
| UBS | Maintained | Neutral | $25 $27 | Apr 13, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $27 $28 | Apr 10, 2026 |
| B of A Securities | Maintained | Neutral | $27 $26 | Apr 9, 2026 |
| Guggenheim | Maintained | Buy | $35 $36 | Mar 24, 2026 |
| HSBC | Maintained | Buy | $29 $32 | Mar 17, 2026 |
| Argus Research | Upgraded from Hold | Buy | $35 | Mar 2, 2026 |
| RBC Capital | Initiated | Underperform | $25 | Feb 25, 2026 |
| Barclays | Initiated | Underweight | $25 | Feb 20, 2026 |
| Freedom Broker | Maintained | Buy | $35 $33 | Feb 9, 2026 |
| Cantor Fitzgerald | Reiterated | Neutral | $27 | Feb 4, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $24 $27 | Jan 27, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $28 $27 | Dec 17, 2025 |
| B of A Securities | Maintained | Neutral | $29 $28 | Dec 15, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $32 $28 | Dec 12, 2025 |
34 filings from 11 insiders · 3 buy / 2 sell over 6m
Officers and directors of PFE, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| BOURLA ALBERTDirector; Officer, Chairman & CEO | GrantPhantom Stock Units SSP | 21 | $28.46 | $598 | Aug 31, 2026 |
| BOURLA ALBERTChief Executive Officer | Buy | 38.0k | $26.34 | $1.00M | Aug 12, 2026 |
| BLAYLOCK RONALD EDirector | Buy | 39.2k | $25.46 | $999k | Aug 5, 2026 |
| BUCKLEY MORTIMER J.Director | Buy | 37.6k | $25.52 | $960k | Aug 5, 2026 |
| DAMICO JENNIFER B.Officer | Sell | 3.3k | $25.40 | $83k | Aug 5, 2026 |
| DAMICO JENNIFER B.Officer | Sell | 2.0k | $25.70 | $51k | Jun 9, 2026 |
| DAMICO JENNIFER B.Officer | Grant | 21.7k | — | — | Mar 3, 2026 |
| BOSHOFF CHRISTOFFELOfficer | Grant | 13.4k | — | — | Feb 25, 2026 |
| SAHNI PAYALOfficer | Exercise | 56.9k | $33.82 | $1.92M | Feb 25, 2026 |
| MCDERMOTT MICHAELOfficer | Exercise | 37.9k | $33.82 | $1.28M | Feb 25, 2026 |
| DAMICO JENNIFER B.Officer | Exercise | 17.6k | $33.82 | $594k | Feb 25, 2026 |
| BOURLA ALBERTChief Executive Officer | Exercise | 491.6k | $33.82 | $16.63M | Feb 25, 2026 |
| LANKLER DOUGLAS MOfficer | Exercise | 122.9k | $33.82 | $4.16M | Feb 25, 2026 |
| FONSECA LIDIA PH.D.Officer | Exercise | 56.9k | $33.82 | $1.92M | Feb 25, 2026 |
| DAMICO JENNIFER B.Officer | Grant | 5.6k | — | — | Mar 4, 2025 |
| DAMICO JENNIFER B.Officer | Sell | 2.5k | $25.93 | $65k | Mar 4, 2025 |
| BOSHOFF CHRISTOFFELOfficer | Grant | 17.4k | — | — | Feb 27, 2025 |
| MCDERMOTT MICHAELOfficer | Exercise | 48.4k | $31.31 | $1.52M | Feb 27, 2025 |
| DAMICO JENNIFER B.Officer | Exercise | 22.4k | $31.31 | $702k | Feb 27, 2025 |
| SAHNI PAYALOfficer | Exercise | 19.1k | $31.31 | $597k | Feb 27, 2025 |
No analyst notes on PFE yet.
Analyst Ratings
26 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 8 | 16 | 1 | 1 | Hold2.68 |
| 1 mo ago | 2 | 8 | 16 | 1 | 1 | Hold2.68 |
| 2 mo ago | 2 | 8 | 16 | 1 | 1 | Hold2.68 |
| 3 mo ago | 2 | 9 | 16 | 1 | 1 | Hold2.66 |